NITRITE/COLLAGEN REACTIONS IN AGING AND SMOKING
衰老和吸烟中的亚硝酸盐/胶原蛋白反应
基本信息
- 批准号:6044277
- 负责人:
- 金额:$ 10.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-01 至 2004-02-28
- 项目状态:已结题
- 来源:
- 关键词:aging ascorbate biomarker chemical reaction collagen crosslink cytotoxicity environmental toxicology free radical scavengers high performance liquid chromatography human tissue nitric oxide nitrites postmortem protein protein interaction protein structure retinoids smoking statistics /biometry tobacco abuse tocopherols tyrosine analog
项目摘要
Although nitrite reactions have been studied in the past, the specific reaction with collagen and its role in aging has never been examined. We have recently observed that in vitro nitrite-treated collagen shows similarities with aged human collagen. Shared properties include the formation of a unique tyrosine derivative we call compound N, a decease in unmodified tyrosine residues, the accumulation of a yellowish chromophore absorbing at 350 nm, and an increase in collagen cross-linking. Increased cross-linking, evidenced by a decreased susceptibility to enzymatic digestion, results in the stiffening of collagen and may account for the stiffening of human blood vessels, lung, and skin which occurs with aging. The majority of human exposure to nitrite results from endogenous nitric oxide production and exogenous sources which include cigarette smoking and cured meat ingestion. In order to establish the in vivo significance of the nitrite/collagen reaction to age-related changes in human collagen we will develop methods to detect biomarkers of the reaction (especially tyrosine derivatives such as compound N, 3-nitrotyrosine, dityrosine, diazotyrosine and deaminated diazotyrosine). Kinetics on the reactions between nitrite and potential reaction intermediates will be conduced in order to more precisely define the mechanism of reaction involved. The biomarkers and reaction intermediates will be identified by reverse phase HPLC amino acid analysis with photodiode array, fluorescence, and electrochemical in-line detection systems. The methods for biomarker detection will be used to compare collagen extracted from the skin, aorta, and lung of young and old individuals. Degree of cross-linking and tyrosine content will also be determined for each collagen sample. Statistical analyses will include multiple logistic regressions with age and smoking as independent variables. Finally, we will examine the effectiveness of free radical scavengers such as vitamins A, C and E to modulate these reactions in vitro. Because cigarette smoking is a major source of an individual's exogenous nitrite exposure, the nitrite/collagen reaction may provide important clues to the pathogenesis of disease processes associated with both aging and cigarette smoking. These include a variety of atherosclerotic vascular diseases, chronic obstructive pulmonary disease, premature sign wrinkling, and age-related lens cataracts.
虽然过去已经研究过亚硝酸盐的反应,但与胶原蛋白的具体反应及其在衰老中的作用从未被研究过。我们最近观察到,体外亚硝酸盐处理的胶原蛋白与衰老的人类胶原蛋白有相似之处。共有的特性包括形成一种独特的酪氨酸衍生物,我们称之为化合物N,未修饰的酪氨酸残基减少,在350 nm处吸收的淡黄色发色团的积累,以及胶原交联的增加。交联增加,对酶消化的敏感性降低,导致胶原蛋白硬化,并可能解释随着年龄增长而发生的人类血管、肺和皮肤硬化。人类接触亚硝酸盐的大多数原因是内源性一氧化氮的产生和外源性来源,包括吸烟和食用腌肉。为了确定亚硝酸盐/胶原蛋白反应对人体胶原蛋白年龄相关变化的体内意义,我们将开发检测该反应的生物标志物的方法(特别是酪氨酸衍生物,如复合N, 3-硝基酪氨酸,二酪氨酸,重氮酪氨酸和脱氨重氮酪氨酸)。为了更精确地确定所涉及的反应机理,将对亚硝酸盐与潜在反应中间体之间的反应进行动力学研究。生物标记物和反应中间体将通过反相高效液相色谱氨基酸分析、光电二极管阵列、荧光和电化学在线检测系统进行鉴定。生物标志物检测方法将用于比较从年轻人和老年人的皮肤、主动脉和肺部提取的胶原蛋白。交联度和酪氨酸含量也将被确定为每个胶原样品。统计分析将包括以年龄和吸烟为自变量的多重逻辑回归。最后,我们将检验自由基清除剂如维生素A、C和E在体外调节这些反应的有效性。由于吸烟是个体外源性亚硝酸盐暴露的主要来源,因此亚硝酸盐/胶原蛋白反应可能为与衰老和吸烟相关的疾病过程的发病机制提供重要线索。这些疾病包括各种动脉粥样硬化性血管疾病、慢性阻塞性肺疾病、过早征象皱纹和年龄相关性晶状体白内障。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID C PAIK其他文献
DAVID C PAIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID C PAIK', 18)}}的其他基金
Therapeutic Corneal Cross-linking Using Aliphatic Beta-Nitroalcohols
使用脂肪族 β-硝基醇进行治疗性角膜交联
- 批准号:
8616069 - 财政年份:2011
- 资助金额:
$ 10.33万 - 项目类别:
Therapeutic Corneal Cross-linking Using Aliphatic Beta-Nitroalcohols
使用脂肪族 β-硝基醇进行治疗性角膜交联
- 批准号:
8228144 - 财政年份:2011
- 资助金额:
$ 10.33万 - 项目类别:
Therapeutic Corneal Cross-linking Using Aliphatic Beta-Nitroalcohols
使用脂肪族 β-硝基醇进行治疗性角膜交联
- 批准号:
8435517 - 财政年份:2011
- 资助金额:
$ 10.33万 - 项目类别:
Therapeutic Corneal Cross-Linking Using Formaldehyde Releasing Agents
使用甲醛释放剂进行治疗性角膜交联
- 批准号:
9106336 - 财政年份:2011
- 资助金额:
$ 10.33万 - 项目类别:
Therapeutic Corneal Cross-Linking Using Formaldehyde Releasing Agents
使用甲醛释放剂进行治疗性角膜交联
- 批准号:
9233107 - 财政年份:2011
- 资助金额:
$ 10.33万 - 项目类别:
Therapeutic Corneal Cross-linking Using Aliphatic Beta-Nitroalcohols
使用脂肪族 β-硝基醇进行治疗性角膜交联
- 批准号:
8040254 - 财政年份:2011
- 资助金额:
$ 10.33万 - 项目类别:
A Novel Treatment for Keratoconus and Keratectasias using Nitro Technology
使用硝基技术治疗圆锥角膜和角膜扩张症的新方法
- 批准号:
7754376 - 财政年份:2009
- 资助金额:
$ 10.33万 - 项目类别:
A Novel Treatment for Keratoconus and Keratectasias using Nitro Technology
使用硝基技术治疗圆锥角膜和角膜扩张症的新方法
- 批准号:
7588578 - 财政年份:2009
- 资助金额:
$ 10.33万 - 项目类别:
NITRITE/COLLAGEN REACTIONS IN AGING AND SMOKING
衰老和吸烟中的亚硝酸盐/胶原蛋白反应
- 批准号:
6629663 - 财政年份:2000
- 资助金额:
$ 10.33万 - 项目类别:
NITRITE/COLLAGEN REACTIONS IN AGING AND SMOKING
衰老和吸烟中的亚硝酸盐/胶原蛋白反应
- 批准号:
6509365 - 财政年份:2000
- 资助金额:
$ 10.33万 - 项目类别:
相似海外基金
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10502613 - 财政年份:2022
- 资助金额:
$ 10.33万 - 项目类别:
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10644023 - 财政年份:2022
- 资助金额:
$ 10.33万 - 项目类别:
Ascorbate and glutathione integrate the control of grapevine development
抗坏血酸和谷胱甘肽整合控制葡萄树的发育
- 批准号:
DP210102178 - 财政年份:2022
- 资助金额:
$ 10.33万 - 项目类别:
Discovery Projects
Finessing, Extending and Developing an Overview of the Regulation of Ascorbate in plants (FEDORA)
精炼、扩展和发展植物中抗坏血酸的调控概述 (FEDORA)
- 批准号:
BB/W006553/1 - 财政年份:2022
- 资助金额:
$ 10.33万 - 项目类别:
Research Grant
Finessing, Extending and Developing an Overview of the Regulation of Ascorbate in plants (FEDORA)
精炼、扩展和发展植物中抗坏血酸的调控概述 (FEDORA)
- 批准号:
BB/W006707/1 - 财政年份:2022
- 资助金额:
$ 10.33万 - 项目类别:
Research Grant
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10582571 - 财政年份:2021
- 资助金额:
$ 10.33万 - 项目类别:
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10210088 - 财政年份:2021
- 资助金额:
$ 10.33万 - 项目类别:
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10374915 - 财政年份:2021
- 资助金额:
$ 10.33万 - 项目类别:
Regulation of light-dependent synthesis of L-ascorbate in plants
植物中 L-抗坏血酸光依赖性合成的调控
- 批准号:
19K06702 - 财政年份:2019
- 资助金额:
$ 10.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reversing age-related reductions in heat loss responses via the administration of ascorbate
通过服用抗坏血酸逆转与年龄相关的热损失反应减少
- 批准号:
525181-2018 - 财政年份:2018
- 资助金额:
$ 10.33万 - 项目类别:
University Undergraduate Student Research Awards